Hunter et al. profiled the phosphoproteome and transcriptome of Eμ-Myc lymphomas in an either wild-type or perturbed NF-κB complex genetic background that were treated with or without Chk1 inhibitor [5]. This evidence concerns the gene NFKB1 and lymphoma.